FDA Archives - Page 4 of 4 - GO2 for Lung Cancer

2019 Forecast for Lung Cancer Research and Treatments

Last year was an exciting year for lung cancer research with more U.S. Food and Drug Administration (FDA) approval decisions relevant to lung cancer than ever before. So, what can we expect for 2019? Another eventful year with researchers [...]

New Combination Treatment Approved for Non-Small Cell Lung Cancer

Bethany Johnson (GO2 for Lung Cancer)2020-02-11T09:07:51-06:00December 7th, 2018|Hot Topics, News|

The Food and Drug Administration (FDA) approved atezolizumab (TECENTRIQ®), an immunotherapy drug, in combination with bevacizumab, paclitaxel, and carboplatin for the first-line treatment of patients with metastatic non-squamous, non-small cell lung cancer (NSq NSCLC) with no EGFR or ALK [...]